You may have heard the term a third dose or a booster shot for the COVID19 vaccine. To clarify, The CDC had already approved a third dose of the Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine for people with moderately to severely compromised immune systems. This includes people who have received an organ transplant and are taking medication to suppress their immune system. Learn more about receiving a third dose at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html.
Now, the CDC has approved a booster shot for both certain populations and for people who work in high risk work settings who have received the two-dose Pfizer-BioNTech COVID-19 vaccine. This includes :
- people 65 years and older and residents in long-term care settings should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series,
- people aged 50–64 years with underlying medical conditions should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series,
- people aged 18–49 years with underlying medical conditions may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks, and
- people aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.
Read the full CDC press release at https://www.cdc.gov/media/releases/2021/p0924-booster-recommendations-.html.
